Various factors, such as rise in prevalence of chronic disorders, growing preference for self-injection, anticipated growth of biologics (including vaccines) and biosimilars markets, potential applications in pen-injectors and autoinjectors, and the increasing focus on the prevention of needlestick injuries, are likely to drive growth within the prefilled syringes market.
To order this 550+ page report, which features 150+ figures and 290+ tables, please visit this link
Key Market Insights
100 prefilled syringes are presently available / under development
Around 70% of these products have glass barrels. It is worth mentioning that majority (16) of the plastic barrel syringes are fabricated using cyclo olefin polymer.
Around 30 companies claim to manufacture add-on / integrated syringe safety products
Examples of players that manufacture add-on safety devices include (in alphabetic order, no selection criteria) Alfa Corpuscles, Biocorp, Credence Medsystems, Nemera, Schreiner Medipharm and Tip-Top.
In order to gain competitive edge in the market, manufacturers are actively engaged in developing patient friendly products
The report features a detailed competitiveness analysis of the various prefilled syringes, taking into consideration the supplier power (based on the employee size of developer / manufacturer and their respective annual revenues) and key product specifications, such as number of chambers in the barrel, number of needle systems, volume of the barrel, technological advancement / user-friendliness and other distinguishing features.
Close to 90 drugs have been approved in combination with prefilled syringes, over the last seven years
Interestingly, majority (53%) of the abovementioned combination products are antibody-based drug candidates. Currently, the next most popular class of therapeutics is vaccines, representing more than 15% of approved prefilled syringe combination products.
110+ clinical candidates are likely to be developed in combination with prefilled syringes in future
The report features insights on the likelihood of over 250+ marketed products and pipeline candidates, being developed in combination with prefilled syringes. Further, we identified 100+ innovator companies that are likely to enter into partnership with prefilled syringe manufacturers in the foreseen future
Currently, the big pharma focus is on developing prefilled combination products for autoimmune disorders
Insights on the initiatives of the top 20 pharmaceutical companies, highlighting their present priorities in terms of therapeutic areas and type of drug product to be developed in combination with prefilled syringes, are available in the full report.
By 2030, prefilled syringes of vaccines and peptide drugs are likely to capture around 40% of the market share
On the other hand, revenues from the sales of prefilled syringe combination products of small molecule and antibody-based drugs, are estimated to grow at annualized rates of 8% and 5.9%, respectively.
To request a sample copy / brochure of this report, please visit this link
Key Questions Answered
Who are the key players engaged in the manufacturing of prefilled syringes, across the globe?
What are the prevalent trends within the prefilled syringes market?
What are the current regulatory requirements for securing marketing authorizations for prefilled syringe combination products, across different countries?
What technological advances have taken place in the prefilled syringes market?
What are the key growth drivers within the prefilled syringes market?
Who are the key contract service providers in this domain?
How is the current and future market opportunity likely to be distributed across key market segments?
The financial opportunity within the prefilled syringes market has been analyzed across the following segments:
Target therapeutic area
Type of syringe
Type of syringe barrel material
Number of barrel chambers
Key geographical regions
Middle East and Africa
The report features inputs from eminent industry stakeholders, according to whom, over time, the demand for prefilled syringes has increased in the developing geographies as well, particularly within the BRICS nations. The report includes detailed transcripts of discussions held with the following experts:
Matthew Young (Founder and Chief Technology Officer, Oval Medical Technologies)
Anonymous (Chief Executive Officer, Small Medical Device Company)
Kirti Maheshwari (Chief Technical Officer, Intas Pharmaceuticals)
Gregor Kawaletz (Chief Commercial Officer, IDT Biologika)
Kevin Cancelliere and Tibor Hlobik (Marketing Directors, West Pharmaceutical)
Marco Pederiva (Marketing & Sales Director, Lonstroff)
Anonymous (Design Director, Large Design Company)
The research covers profiles of key players (listed below), featuring an overview of the companies, their financial information (if available), information on their product portfolio, recent developments and an informed future outlook.
WEGO Prefills Pharmaceutical Packaging
Shandong Pharmaceutical Glass
Shandong Zibo Minkang Pharmaceutical Packing
For additional details, please visit
or email [email protected]
You may also be interested in the following titles:
Global Autoinjectors Market (3rd Edition), 2020-2030
Novel Vaccine Delivery Devices Market, 2019-2030
Microneedles and Needle-Free Injection Systems / Jet Injectors (Devices based on Spring, Gas and Other Mechanisms) Market, 2019-2030
Medical Device Labels Manufacturing Market, 2019 - 2030
+1 (415) 800 3415
+44 (122) 391 1091